Skip to content

To evaluate the analgesic effect of pecto-intercostal fascial block (PIFB) in thoracic surgery

To evaluate the analgesic effect of pecto-intercostal fascial block (PIFB) in thoracic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068197
Enrollment
Unknown
Registered
2023-02-09
Start date
2023-02-09
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radical mastectomy and heart surgery

Interventions

Breast PECS group (P group):PECS II block
Breast PIFB combined with PECS group (P+P group):Breast PIFB combined with PECS
Cardiac Surgery Control Group:not have
Cardiac surgery PIFB group:Bilateral pecto-intercostal fascial block (PIFB)
Cardiac surgery bilateral transverse thoracic plane (TTP) block group:Bilateral transverse thoracic plane (TTP) block

Sponsors

Affiliated Hospital of Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Part I: To evaluate the analgesic effect of PIFB combined with pectoral muscle block in patients undergoing radical mastectomy Inclusion criteria: patients scheduled for unilateral radical mastectomy, aged 20-60 years, female, American Society of Anesthesiologists physical status ?-?, no serious systemic diseases, no allergy to local anesthetics and other anesthetics, no anticoagulant therapy or coagulation dysfunction, agreed to the anesthesia regimen of this study, and signed the informed consent form. Part II: To evaluate the analgesic effect of bilateral PIFB in cardiac surgery Inclusion criteria: age 18-70 years, median sternotomy, ASA classification: class III-IV

Exclusion criteria

Exclusion criteria: Part I: Exclusion criteria: local anesthetic poisoning, allergic reactions during anesthesia, postoperative cognitive dysfunction and unable to cooperate with follow-up. Part II: Exclusion criteria: emergency surgery, allergy to local anesthetics, congestive heart failure, liver or renal failure, history of substance abuse or chronic pain, psychiatric problems, secondary surgery, inability to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Intraoperative consumption of remifentanil;Postoperative Pain Score;Intraoperative consumption of sufentanil;

Countries

China

Contacts

Public ContactYang Dawei

Affiliated Hospital of Yangzhou University

yangdawei307@163.com13773531263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026